siRNA-Mediated Knock-Down of P-Glycoprotein Expression Reveals Distinct Cellular Disposition of Anticancer Tyrosine Kinases Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|4|2|114-119

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.4, Iss.2, 2010-04, pp. : 114-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

siRNA Knock-Down of RANK Signaling to Control Osteoclast-Mediated Bone Resorption

By Wang Yuwei   Grainger David  

Pharmaceutical Research, Vol. 27, Iss. 7, 2010-07 ,pp. : 1273-1284

Springer Publishing Company

Access to resources Recommend Favorite

Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome

By  

Current Drug Metabolism, Vol. 10, Iss. 4, 2009-05 ,pp. : 322-328

Bentham Science Publishers

Access to resources Recommend Favorite

P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor

By  

Drug Metabolism Letters, Vol. 4, Iss. 4, 2010-12 ,pp. : 202-212

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutically Targeted Anticancer Agents: Inhibitors of Receptor Tyrosine Kinases

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 273-283

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery Strategies for siRNA-mediated Gene Silencing

By  

Current Drug Delivery, Vol. 3, Iss. 2, 2006-04 ,pp. : 147-155

Bentham Science Publishers

Access to resources Recommend Favorite